Class IIICompleted

Micafungin for injection recall

FDA recall D-0595-2024 · initiated Jul 2, 2024

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Why it was recalled

Cross contamination with other products

Details

Product: Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1725-01 (vial), NDC 70710-1725-06 (outer box).
Recalling company: Zydus Pharms USA
Classification: Class III
Status: Completed
Type: Voluntary: Firm initiated
Distribution: Nationwide in the USA and Puerto Rico
Initiated: Jul 2, 2024
FDA report date: Jul 17, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0595-2024 ↗

← All drug recalls